Similasan Eye Drops Lawsuit: Claim Deadline Has Passed

What is the Similasan Eye Drops Lawsuit about?

Similasan Corp. has agreed to pay $3.575 million to resolve allegations that its homeopathic eye-care products—sold under Similasan as well as CVS and Walgreens store brands—were falsely marketed as FDA-approved, sterile and produced under current Good Manufacturing Practices. Consumers can claim $2.50 per covered product (up to four items without proof of purchase) and an unlimited number with valid receipts, subject to pro-rata adjustment. Eligibility, claim review, payment timing, and any payment amount are determined by the settlement administrator, court-approved terms, or applicable refund program. Payout does not administer the settlement, determine eligibility, or guarantee payment.

Who qualifies for the Similasan Eye Drops Lawsuit?

You may qualify for the Similasan Eye Drops Lawsuit if you meet the eligibility requirements below. Eligibility is finally determined by the settlement administrator, not by Payout.

• Purchased covered Similasan, CVS or Walgreens eye drops between 2017-09-11 and 2025-02-20
• Product was for personal use (not for resale)

Frequently asked questions

Before you file

If this is your first claim, how to claim a class action settlement walks through the process end to end, and what class action settlements actually pay per person explains how the amount is decided before you spend time on the form. Many cases need no receipts at all — see settlements with no proof of purchase.